KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that five abstracts, including one late-breaking submission, have been accepted for presentation at the 2026 Global Angioedema Leadership ...
Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology ...
That small detail is going to be left to a 100-strong panel of random Brits, chosen to represent a cross-section of the population. They will decide which aspects of public life are most in need of ...
Poster Presentation Title: Real World Clinical Experience from ENABLE, the First Phase 4 Observational Study for Patients with Relapsing Multiple Sclerosis Initiating Ublituximab Presentation ...
NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with ...
Vista Equity Partners runs its private equity operations from Austin, with investments centered on enterprise software, data, and tech-focused companies. As of 2025, the firm reports over $100 billion ...
SAN JOSE, CA, UNITED STATES, February 24, 2026 / EINPresswire.com / — TapClicks, the leader in Smart Marketing solutions, today announced the launch of SmartStory, a new AI-powered solution that ...
SAN JOSE, CA, UNITED STATES, February 24, 2026 /EINPresswire.com/ — TapClicks, the leader in Smart Marketing solutions, today announced the launch of SmartStory, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results